Nonnucleoside Inhibitor of Measles Virus RNA-Dependent RNA Polymerase Complex Activity

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2007-04-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.00289-07PMID 17470652PMCID PMC1913224
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study.

  2007cited by this paper
• Two Domains That Control Prefusion Stability and Transport Competence of the Measles Virus Fusion Protein

  2006cited by this paper
• Hendra and Nipah viruses: different and dangerous

  2006cited by this paper
• An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults

  2006cited by this paper
• Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation

  2006cited by this paper
• Structural disorder within the replicative complex of measles virus: functional implications.

  2006cited by this paper
• Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses.

  2006cited by this paper
• A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial.

  2006cited by this paper
• Nonpeptide inhibitors of measles virus entry.

  2006cited by this paper
• Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose.

  2005cited by this paper
• Design of a Small-Molecule Entry Inhibitor with Activity against Primary Measles Virus Strains

  2005cited by this paper
• Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein.

  2005cited by this paper
• Paramyxovirus membrane fusion: Lessons from the F and HN atomic structures

  2005cited by this paper
• Progress in reducing measles mortality--worldwide, 1999-2003.

  2005cited by this paper
• Inhibitors of Measles Virus

  2004cited by this paper
• A target site for template-based design of measles virus entry inhibitors.

  2004cited by this paper
• Compound decomposition: a new drug discovery tool?

  2004cited by this paper
• Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study.

  2004cited by this paper
• Nipah virus conforms to the rule of six in a minigenome replication assay.

  2004cited by this paper
• Kinase inhibitors: not just for kinases anymore.

  2003cited by this paper
• Structural features of paramyxovirus F protein required for fusion initiation.

  2003cited by this paper
• Structural disorder and modular organization in Paramyxovirinae N and P.

  2003cited by this paper
• The C-terminal Domain of the Measles Virus Nucleoprotein Is Intrinsically Disordered and Folds upon Binding to the C-terminal Moiety of the Phosphoprotein*

  2003cited by this paper
• Efficient Isolation of Wild Strains of Canine Distemper Virus in Vero Cells Expressing Canine SLAM (CD150) and Their Adaptability to Marmoset B95a Cells

  2003cited by this paper
• A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

  2002cited by this paper
• Switchable Reactivity: The Site‐Selective Functionalization of Trifluoromethyl‐Substituted Pyrazoles

  2002cited by this paper
• Membrane Fusion Tropism and Heterotypic Functional Activities of the Nipah Virus and Hendra Virus Envelope Glycoproteins

  2002cited by this paper
• Strength of Envelope Protein Interaction Modulates Cytopathicity of Measles Virus

  2002cited by this paper
• Measles epidemic in the Netherlands, 1999-2000.

  2002cited by this paper
• Gene transfer into neurons from hippocampal slices: comparison of recombinant Semliki Forest Virus, adenovirus, adeno-associated virus, lentivirus, and measles virus.

  2001cited by this paper
• [Measles epidemic in the Netherlands, 1999-2000].

  2001cited by this paper
• Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study

  2001cited by this paper
• Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications.

  2001cited by this paper
• CD150 (SLAM) Is a Receptor for Measles Virus but Is Not Involved in Viral Contact-Mediated Proliferation Inhibition

  2001cited by this paper
• The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion.

  2001cited by this paper
• Highly Active Antiretroviral Therapy Decreases Mortality and Morbidity in Patients with Advanced HIV Disease

  2001cited by this paper
• Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults

  2001cited by this paper
• SLAM(CDw150)is a cellular receptor for measles virus

  2001cited by this paper
• Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase

  2001cited by this paper
• Molecular biology of Hendra and Nipah viruses.

  2001cited by this paper
• The Mathematics of Infectious Diseases

  2000cited by this paper
• SLAM (CDw150) is a cellular receptor for measles virus

  2000cited by this paper
• Generation of Bovine Respiratory Syncytial Virus (BRSV) from cDNA: BRSV NS2 Is Not Essential for Virus Replication in Tissue Culture, and the Human RSV Leader Region Acts as a Functional BRSV Genome Promoter

  1999cited by this paper
• Observation of Measles Virus Cell-to-Cell Spread in Astrocytoma Cells by Using a Green Fluorescent Protein-Expressing Recombinant Virus

  1999cited by this paper
• A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

  1999cited by this paper
• Requirements for different components of the host cell cytoskeleton distinguish ecotropic murine leukemia virus entry via endocytosis from entry via surface fusion

  1997cited by this paper
• Orthomyxoviridae: The Viruses and Their Replication.

  1996cited by this paper
• Paramyxoviridae : The virus and their replication

  1996cited by this paper
• Rescue of synthetic measles virus minireplicons: measles genomic termini direct efficient expression and propagation of a reporter gene.

  1995cited by this paper
• Active vacuolar H+ATPase is required for both endocytic and exocytic processes during viral infection of BHK-21 cells.

  1994cited by this paper
• The human CD46 molecule is a receptor for measles virus (Edmonston strain).

  1993cited by this paper
• Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus

  1993cited by this paper
• Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses

  1992cited by this paper
• 5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl)tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans As cell-viability indicators

  1991cited by this paper
• Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

  1990cited by this paper
• The measles virus

  1980influential reference
• The method of 'right and wrong cases' ('constant stimuli') without Gauss's formulae

  year unknowncited by this paper

• High-throughput split-GFP antiviral screening assay against fusogenic paramyxoviruses.

  2025cites this paper
• “A study on prevalence of measles at tertiary care hospital and study on demographic profile of patients infected with measles virus”

  2024cites this paper
• Structural basis of paramyxo- and pneumovirus polymerase inhibition by non-nucleoside small-molecule antivirals

  2024cites this paper
• Repurposing an In Vitro Measles Virus Dissemination Assay for Screening of Antiviral Compounds

  2022influential citation
• Small-molecule polymerase inhibitor protects non-human primates from measles and reduces shedding

  2021cites this paper
• Highly Potent Host-Specific Small-Molecule Inhibitor of Paramyxovirus and Pneumovirus Replication with High Resistance Barrier

  2021influential citation
• Advances in Antiviral Therapy for Subacute Sclerosing Panencephalitis

  2021cites this paper
• Brief Introduction of Measles Virus and Its Therapeutic Strategies

  2021cites this paper
• Antiviral Screen against Canine Distemper Virus-Induced Membrane Fusion Activity

  2021influential citation
• Nuphar lutea Extracts Exhibit Anti-Viral Activity against the Measles Virus

  2020cites this paper
• Therapeutic targeting of measles virus polymerase with ERDRP-0519 suppresses all RNA synthesis activity

  2020influential citation
• Measles Resurgence and Drug Development.

  2020cites this paper
• IDENTIFICATION OF NOVEL DRUGGABLE TARGETS IN TWO MEMBERS OF MONONEGAVIRALES

  2019cites this paper
• Measles Encephalitis: Towards New Therapeutics

  2019cites this paper
• RNA-Dependent RNA Polymerases and Their Emerging Roles in Antiviral Therapy

  2019cites this paper
• Measles Virus Enters Breast and Colon Cancer Cell Lines through a PVRL4-Mediated Macropinocytosis Pathway

  2017cites this paper
• New antiviral approaches for respiratory syncytial virus and other mononegaviruses: Inhibiting the RNA polymerase.

  2016cites this paper
• Chemical Space Mapping and Structure-Activity Analysis of the ChEMBL Antiviral Compound Set

  2016cites this paper
• Modulation of Re-initiation of Measles Virus Transcription at Intergenic Regions by PXD to NTAIL Binding Strength

  2016cites this paper
• Organization, Function, and Therapeutic Targeting of the Morbillivirus RNA-Dependent RNA Polymerase Complex

  2016cites this paper
• The paramyxovirus polymerase complex as a target for next-generation anti-paramyxovirus therapeutics

  2015cites this paper
• Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein

  2015cites this paper
• Synergizing vaccinations with therapeutics for measles eradication

  2014influential citation
• Krumm Against a Lethal Morbillivirus Infection in a Large Animal Model An Orally Available , Small-Molecule Polymerase Inhibitor Shows Efficacy

  2014cites this paper
• The Role of the Hendra Virus and Nipah Virus Attachment Glycoproteins in Receptor Binding and Antibody Neutralization

  2014cites this paper
• The RNA-dependent-RNA polymerase, an emerging antiviral drug target for the Hendra virus.

  2014cites this paper
• Novel antiviral strategies for feline coronavirus and feline calicivirus

  2014cites this paper
• An Orally Available, Small-Molecule Polymerase Inhibitor Shows Efficacy Against a Lethal Morbillivirus Infection in a Large Animal Model

  2014cites this paper
• Dual Myxovirus Screen Identifies a Small-Molecule Agonist of the Host Antiviral Response

  2013cites this paper
• Protein-protein and protein-small-molecule inhibitor interactions in the measles virus replication complex

  2013cites this paper
• In vitro inhibition of canine distemper virus by flavonoids and phenolic acids: implications of structural differences for antiviral design.

  2013cites this paper
• Asymmetric synthesis of host-directed inhibitors of myxoviruses

  2013cites this paper
• Independent Structural Domains in Paramyxovirus Polymerase Protein*

  2012cites this paper
• INSTITUTO OSWALDO CRUZ Pós-Graduação em Medicina Tropical

  2012cites this paper
• Non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase: synthesis, structure-activity relationships, and pharmacokinetics.

  2012cites this paper
• Subtractive Genomics Approach to Identify Putative Drug Targets and Identification of Drug-like Molecules for Beta Subunit of DNA Polymerase III in Streptococcus Species

  2012cites this paper
• Host-directed Inhibitors of Myxoviruses: Synthesis and in vitro Biochemical Evaluation.

  2011cites this paper
• Inhibition of viral RNA synthesis in canine distemper virus infection by proanthocyanidin A2.

  2011cites this paper
• Potent Host-Directed Small-Molecule Inhibitors of Myxovirus RNA-Dependent RNA-Polymerases

  2011influential citation
• Real-time bioluminescent assay for inhibitors of RNA and DNA polymerases and other ATP-dependent enzymes.

  2011cites this paper
• Measles virus infection of the CNS: human disease, animal models, and approaches to therapy

  2010cites this paper
• Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro.

  2010cites this paper
• Flexibility in cell targeting by pseudotyping lentiviral vectors.

  2010cites this paper
• Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus.

  2010cites this paper
• New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

  2010cites this paper
• Target Analysis of the Experimental Measles Therapeutic AS-136A

  2009influential citation
• Measles control--can measles virus inhibitors make a difference?

  2009cites this paper
• 2-Substituted-4,5-dihydroxypyrimidine-6-carboxamide antiviral targeted libraries.

  2009cites this paper
• Cancer and virus leads by HTS, chemical design and SEA data mining.

  2009cites this paper
• Chapter 5. In vivo analysis of the decay of transcripts generated by cytoplasmic RNA viruses.

  2008cites this paper
• High-Throughput Screening—Based Identification of Paramyxovirus Inhibitors

  2008cites this paper
• Cell-based assays to identify inhibitors of viral disease

  2008cites this paper
• Potent non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase complex.

  2008cites this paper
• Non-nucleoside inhibitors of the measles virus RNA-dependent RNA polymerase complex activity: Synthesis and in vitro evaluation.

  2007cites this paper